Galatea Bio logo

Galatea Bio Funding & Investors

Hialeah, FL

Galatea Bio, a US-based biotechnology company was founder by Carlos Bustamante, Nicholas Katsanis and Alexander Ioannidis. Our mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research. We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests, treatments, and cures that will improve the lives of all.

galatea.bio

Total Amount Raised: $28,656,000

Galatea Bio Funding Rounds

  • Series Unknown

    $8,000,000

    Series Unknown Investors

    F-Prime Capital
    CEI Ventures
    Alexandria Real Estate Equities
    Digitalis Ventures
    AME Cloud Ventures
    Founder Collective
    HBM Genomics
    Helios Investment Partners
    Stanford University
    Alix Ventures
    BIOHUB
  • Debt Financing

    $3,656,000

  • Series A

    $10,000,000

  • Seed

    $7,000,000

    Seed Investors

    Digitalis Ventures
    F-Prime Capital
    Edward Lando
    Pareto Holdings
Funding info provided by Diffbot.